Genetec Technology Berhad Logo

Genetec Technology Berhad

0104.KL

(3.0)
Stock Price

0,82 MYR

12.22% ROA

14.82% ROE

9.41x PER

Market Cap.

659.308.440,00 MYR

3.71% DER

2.38% Yield

25.34% NPM

Genetec Technology Berhad Stock Analysis

Genetec Technology Berhad Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Genetec Technology Berhad Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (18.26%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 DER

The stock has a low debt to equity ratio (13%), which means it has a small amount of debt compared to the ownership it holds

4 Revenue Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

5 Assets Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

6 Net Profit Growth

This company's net profit has been consistently on the rise over the past three years, indicating a strong financial performance and making it an appealing investment opportunity.

7 Buffet Intrinsic Value

The company's stock seems undervalued (30) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

8 PBV

The stock's elevated P/BV ratio (4.31x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

9 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

10 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Genetec Technology Berhad Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Genetec Technology Berhad Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

Genetec Technology Berhad Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Genetec Technology Berhad Revenue
Year Revenue Growth
2005 38.259.849
2006 23.442.244 -63.21%
2007 53.391.152 56.09%
2008 48.875.145 -9.24%
2009 52.527.690 6.95%
2010 123.048.491 57.31%
2011 155.433.512 20.84%
2012 123.112.099 -26.25%
2013 116.212.893 -5.94%
2014 145.870.955 20.33%
2015 129.003.499 -13.08%
2016 70.626.655 -82.66%
2017 101.027.639 30.09%
2018 97.159.781 -3.98%
2019 80.332.272 -20.95%
2020 97.078.092 17.25%
2021 223.559.348 56.58%
2022 294.591.456 24.11%
2023 289.760.000 -1.67%
2023 277.602.400 -4.38%
2024 205.944.000 -34.8%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Genetec Technology Berhad Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Genetec Technology Berhad General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 2.684.211
2006 3.032.042 11.47%
2007 2.595.944 -16.8%
2008 2.765.367 6.13%
2009 2.417.387 -14.39%
2010 6.357.696 61.98%
2011 14.578.156 56.39%
2012 8.787.089 -65.9%
2013 6.147.463 -42.94%
2014 5.842.447 -5.22%
2015 6.352.585 8.03%
2016 5.745.369 -10.57%
2017 10.710.423 46.36%
2018 7.245.493 -47.82%
2019 7.493.137 3.3%
2020 9.435.766 20.59%
2021 11.722.470 19.51%
2022 13.333.717 12.08%
2023 12.624.000 -5.62%
2023 0 0%
2024 16.608.000 100%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Genetec Technology Berhad EBITDA
Year EBITDA Growth
2005 2.633.981
2006 -4.445.454 159.25%
2007 6.879.853 164.62%
2008 10.017.185 31.32%
2009 6.675.146 -50.07%
2010 21.189.056 68.5%
2011 12.430.835 -70.46%
2012 -2.380.895 622.11%
2013 4.688.385 150.78%
2014 8.689.140 46.04%
2015 12.641.082 31.26%
2016 -327.380 3961.29%
2017 9.344.909 103.5%
2018 7.687.820 -21.55%
2019 2.698.250 -184.92%
2020 -1.341.411 301.15%
2021 67.508.078 101.99%
2022 82.180.445 17.85%
2023 81.536.000 -0.79%
2023 76.779.200 -6.2%
2024 27.640.000 -177.78%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Genetec Technology Berhad Gross Profit
Year Gross Profit Growth
2005 6.400.560
2006 -245.662 2705.43%
2007 10.526.649 102.33%
2008 9.867.197 -6.68%
2009 8.435.659 -16.97%
2010 25.948.501 67.49%
2011 27.952.436 7.17%
2012 17.084.284 -63.61%
2013 9.659.368 -76.87%
2014 15.116.593 36.1%
2015 14.926.687 -1.27%
2016 8.511.966 -75.36%
2017 18.519.979 54.04%
2018 19.713.978 6.06%
2019 14.887.553 -32.42%
2020 12.714.876 -17.09%
2021 79.660.613 84.04%
2022 98.434.149 19.07%
2023 92.976.000 -5.87%
2023 87.065.600 -6.79%
2024 40.512.000 -114.91%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Genetec Technology Berhad Net Profit
Year Net Profit Growth
2005 1.893.617
2006 -5.188.826 136.49%
2007 5.478.080 194.72%
2008 8.458.180 35.23%
2009 4.413.410 -91.65%
2010 12.419.792 64.46%
2011 4.048.028 -206.81%
2012 -25.919.830 115.62%
2013 7.005.185 470.01%
2014 4.456.838 -57.18%
2015 4.406.066 -1.15%
2016 -4.027.407 209.4%
2017 5.778.664 169.69%
2018 5.613.508 -2.94%
2019 -166.026 3481.1%
2020 -4.386.317 96.21%
2021 56.399.961 107.78%
2022 66.633.225 15.36%
2023 73.816.000 9.73%
2023 68.898.400 -7.14%
2024 40.632.000 -69.57%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Genetec Technology Berhad Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 1 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Genetec Technology Berhad Free Cashflow
Year Free Cashflow Growth
2005 -6.548.895
2006 -1.765.670 -270.9%
2007 940.485 287.74%
2008 14.259.661 93.4%
2009 -9.082.474 257%
2010 5.548.686 263.69%
2011 -21.572.625 125.72%
2012 18.258.275 218.15%
2013 14.915.228 -22.41%
2014 -6.074.870 345.52%
2015 21.468.151 128.3%
2016 5.514.741 -289.29%
2017 1.964.459 -180.73%
2018 -2.356.012 183.38%
2019 9.208.092 125.59%
2020 17.090.431 46.12%
2021 -107.736.924 115.86%
2022 17.678.733 709.42%
2023 -27.454.000 164.39%
2023 19.644.000 239.76%
2024 -1.098.000 1889.07%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Genetec Technology Berhad Operating Cashflow
Year Operating Cashflow Growth
2005 -4.801.987
2006 506.747 1047.61%
2007 4.366.305 88.39%
2008 16.867.115 74.11%
2009 -6.704.215 351.59%
2010 7.251.129 192.46%
2011 -5.822.323 224.54%
2012 26.526.259 121.95%
2013 15.382.649 -72.44%
2014 -3.866.097 497.89%
2015 22.300.033 117.34%
2016 5.653.071 -294.48%
2017 3.380.252 -67.24%
2018 -832.456 506.06%
2019 9.698.966 108.58%
2020 20.100.245 51.75%
2021 -99.610.218 120.18%
2022 92.352.623 207.86%
2023 -22.263.000 514.83%
2023 42.034.000 152.96%
2024 -3.335.000 1360.39%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Genetec Technology Berhad Capital Expenditure
Year Capital Expenditure Growth
2005 1.746.908
2006 2.272.417 23.13%
2007 3.425.820 33.67%
2008 2.607.454 -31.39%
2009 2.378.259 -9.64%
2010 1.702.443 -39.7%
2011 15.750.302 89.19%
2012 8.267.984 -90.5%
2013 467.421 -1668.85%
2014 2.208.773 78.84%
2015 831.882 -165.52%
2016 138.330 -501.37%
2017 1.415.793 90.23%
2018 1.523.556 7.07%
2019 490.874 -210.38%
2020 3.009.814 83.69%
2021 8.126.706 62.96%
2022 74.673.890 89.12%
2023 5.191.000 -1338.53%
2023 22.390.000 76.82%
2024 -2.237.000 1100.89%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Genetec Technology Berhad Equity
Year Equity Growth
2005 22.060.464
2006 18.138.638 -21.62%
2007 22.609.768 19.78%
2008 28.651.788 21.09%
2009 32.611.958 12.14%
2010 81.541.272 60.01%
2011 82.995.547 1.75%
2012 48.005.315 -72.89%
2013 52.581.536 8.7%
2014 61.212.590 14.1%
2015 67.657.535 9.53%
2016 63.295.609 -6.89%
2017 77.456.391 18.28%
2018 83.358.140 7.08%
2019 81.654.984 -2.09%
2020 84.256.934 3.09%
2021 160.795.186 47.6%
2022 406.297.540 60.42%
2023 442.836.000 8.25%
2023 496.728.000 10.85%
2024 496.728.000 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Genetec Technology Berhad Assets
Year Assets Growth
2005 31.972.210
2006 30.236.655 -5.74%
2007 33.332.276 9.29%
2008 41.321.573 19.33%
2009 53.880.917 23.31%
2010 126.908.587 57.54%
2011 169.781.383 25.25%
2012 135.528.807 -25.27%
2013 112.762.281 -20.19%
2014 161.674.981 30.25%
2015 103.551.107 -56.13%
2016 98.218.391 -5.43%
2017 117.674.828 16.53%
2018 119.579.024 1.59%
2019 118.692.737 -0.75%
2020 124.403.194 4.59%
2021 294.152.331 57.71%
2022 500.547.265 41.23%
2023 537.891.000 6.94%
2023 567.710.000 5.25%
2024 567.710.000 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Genetec Technology Berhad Liabilities
Year Liabilities Growth
2005 9.911.746
2006 12.098.017 18.07%
2007 10.722.508 -12.83%
2008 12.669.785 15.37%
2009 21.268.959 40.43%
2010 45.367.315 53.12%
2011 86.785.836 47.72%
2012 87.523.492 0.84%
2013 60.180.745 -45.43%
2014 100.462.391 40.1%
2015 35.893.572 -179.89%
2016 34.922.782 -2.78%
2017 40.218.437 13.17%
2018 36.220.884 -11.04%
2019 37.037.753 2.21%
2020 40.146.260 7.74%
2021 133.357.145 69.9%
2022 94.249.725 -41.49%
2023 95.055.000 0.85%
2023 70.982.000 -33.91%
2024 70.982.000 0%

Genetec Technology Berhad Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.35
Net Income per Share
0.09
Price to Earning Ratio
9.41x
Price To Sales Ratio
2.43x
POCF Ratio
44.34
PFCF Ratio
229.88
Price to Book Ratio
1.32
EV to Sales
2.36
EV Over EBITDA
8.19
EV to Operating CashFlow
43.92
EV to FreeCashFlow
223.39
Earnings Yield
0.11
FreeCashFlow Yield
0
Market Cap
0,66 Bil.
Enterprise Value
0,64 Bil.
Graham Number
1.13
Graham NetNet
0.37

Income Statement Metrics

Net Income per Share
0.09
Income Quality
0.21
ROE
0.15
Return On Assets
0.12
Return On Capital Employed
0.14
Net Income per EBT
0.97
EBT Per Ebit
0.98
Ebit per Revenue
0.27
Effective Tax Rate
0.07

Margins

Sales, General, & Administrative to Revenue
0.04
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.34
Operating Profit Margin
0.27
Pretax Profit Margin
0.26
Net Profit Margin
0.25

Dividends

Dividend Yield
0.02
Dividend Yield %
2.38
Payout Ratio
0
Dividend Per Share
0.02

Operating Metrics

Operating Cashflow per Share
0.02
Free CashFlow per Share
0
Capex to Operating CashFlow
0.8
Capex to Revenue
0.04
Capex to Depreciation
1.8
Return on Invested Capital
0.13
Return on Tangible Assets
0.12
Days Sales Outstanding
328.75
Days Payables Outstanding
74.81
Days of Inventory on Hand
28.2
Receivables Turnover
1.11
Payables Turnover
4.88
Inventory Turnover
12.95
Capex per Share
0.02

Balance Sheet

Cash per Share
0,21
Book Value per Share
0,65
Tangible Book Value per Share
0.64
Shareholders Equity per Share
0.64
Interest Debt per Share
0.03
Debt to Equity
0.04
Debt to Assets
0.03
Net Debt to EBITDA
-0.24
Current Ratio
6.8
Tangible Asset Value
0,49 Bil.
Net Current Asset Value
0,35 Bil.
Invested Capital
500016000
Working Capital
0,36 Bil.
Intangibles to Total Assets
0.01
Average Receivables
0,25 Bil.
Average Payables
0,03 Bil.
Average Inventory
13856500
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Genetec Technology Berhad Dividends
Year Dividends Growth
2008 0
2010 0 0%
2011 0 0%
2018 0 0%
2019 0 0%
2024 0 0%

Genetec Technology Berhad Profile

About Genetec Technology Berhad

Genetec Technology Berhad, an investment holding company, designs and manufactures smart automation systems, customized factory automation equipment and integrated systems in Malaysia, Asia, Europe, and North America. It offers assembly, material handling, and in-house machine center solutions; testing and inspection solutions; precision tooling jigs and fixtures; aluminium profiles; and machine parts and tools fabrication services for equipment and replications of systems and equipment. The company serves the e-mobility, energy storage, automotive, hard disk drive, consumer goods, and pharmaceutical industries. Genetec Technology Berhad was incorporated in 1997 and is headquartered in Bandar Baru Bangi, Malaysia.

CEO
Mr. Kem Weng Chin
Employee
345
Address
Seksyen 10
Bandar Baru Bangi, 43650

Genetec Technology Berhad Executives & BODs

Genetec Technology Berhad Executives & BODs
# Name Age
1 Sook Kuan Low MAICSA
Company Secretary
70
2 Mr. Kem Weng Chin
MD & Executive Director
70
3 Mr. Ewe Lee Sow
Chief Operating Officer & Executive Director
70
4 Mr. Kon Hoan Tan
Chief Financial Officer
70
5 Mr. Yik Yong Goh
Senior Vice President of Operations
70

Genetec Technology Berhad Competitors